Sofinnova Partners

VC Paris, France · Founded 1972

Sofinnova Partners is a leading European venture capital firm that backs pioneering entrepreneurs across the life sciences value chain, from seed-stage company creation to late-stage growth. The firm focuses on translating cutting-edge scientific discoveries in biopharma, medtech, and digital medicine into groundbreaking treatments and technologies that address urgent unmet clinical needs.

About Sofinnova Partners

Sofinnova Partners is a Paris-based life sciences specialist and one of Europe’s most established healthcare venture firms, with a long history of investing across biopharma, medtech, industrial biotech, and digital medicine. The firm operates dedicated strategies including its flagship biopharma fund, an MD Start medical device incubation strategy, an industrial biotech vehicle, and a digital medicine fund that targets software, AI, and data-driven health companies. Check sizes vary by strategy but commonly range from low single-digit millions in early commitments to commitments totaling fifteen to thirty million euros or more over the life of an investment when the firm follows on. The natural fit depends on which strategy you target, and founders should be specific in their outreach. Therapeutics teams should approach the biopharma practice; medical device founders the MD Start group; software and AI teams the digital medicine fund. Healthcare AI founders building clinical software, AI-driven diagnostics, or data infrastructure for biopharma R&D have a credible path here, while pure consumer wellness or non-clinical apps do not. Founders should expect rigorous, sector-fluent diligence with scientific and clinical advisors involved early. The best entry path is a warm introduction from a portfolio CEO, a European biotech banker, an academic medical center collaborator, or a strategic at a pharma or device company. Direct outreach via LinkedIn to a partner aligned with your strategy is also a credible path. Expect partner-track engagement and a long-horizon partnership orientation.

Founder reviews

No founder reviews yet. Raised from this fund? Share your experience with other founders.

Healthcare AI tools backed by Sofinnova Partners

Tools made by companies in Sofinnova Partners's portfolio that we cover in the directory.

deepc
deepc
Clinical Decision Support & Reference
deepc's AIDA platform provides clinical AI infrastructure for health systems, integrating various AI applications into diagnostic workflows.

Portfolio companies in our directory

Other portfolio companies

Companies in Sofinnova Partners's portfolio not currently in our directory.

Team

Antoine Papiernik
Chairman & Managing Partner
LinkedIn
Henrijette Richter
Managing Partner
LinkedIn
Graziano Seghezzi
Managing Partner
LinkedIn
Edward Kliphuis
Partner, Digital Medicine Strategy
LinkedIn
Simon Turner
Partner, Digital Medicine Strategy
LinkedIn

Pitch / review this investor

Have you raised from Sofinnova Partners? Founders only — share your honest experience (anonymous OK, moderated before publishing).

Share your experience
Last updated 2026-05-06. Sourced from this fund's published materials.
Suggest an Edit → | Report an issue
AI Tool Finder
AI-powered search. Results may not be comprehensive.